Suppr超能文献

非小细胞肺癌中5q21杂合性缺失:常见现象但无APC突变证据

Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation.

作者信息

Cooper C A, Bubb V J, Smithson N, Carter R L, Gledhill S, Lamb D, Wyllie A H, Carey F A

机构信息

Sir Alastair Currie CRC Laboratories, University of Edinburgh, U.K.

出版信息

J Pathol. 1996 Sep;180(1):33-7. doi: 10.1002/(SICI)1096-9896(199609)180:1<33::AID-PATH642>3.0.CO;2-Y.

Abstract

Four genetic polymorphisms in the APC and MCC genes at chromosome 5q21 were analysed for loss of heterozygosity (LOH) in 97 primary squamous carcinomas and adenocarcinomas of the lung. LOH was identified in at least two polymorphic loci in 41 percent of informative cases. There was no significant difference in the frequency of LOH between squamous carcinomas and adenocarcinomas. Within the adenocarcinoma group, however, LOH appeared to be more common in tumours having a bronchial origin (5/9; 56 per cent) than in parenchymal adenocarcinoma (6/21; 29 per cent). All 32 tumours showing LOH at one or more polymorphic sites were examined for mutations in the mutation cluster region (MCR) of APC by single-strand conformational polymorphism (SSCP) analysis. Mutations were not detected in any of these cases. We therefore propose that it is likely that a tumour suppressor gene on 5q other than APC is involved in the pathogenesis of lung cancer.

摘要

对97例原发性肺鳞癌和腺癌进行分析,检测5号染色体q21区域APC和MCC基因的4个遗传多态性位点,以确定杂合性缺失(LOH)情况。在41%的信息性病例中,至少在两个多态性位点检测到LOH。鳞癌和腺癌的LOH频率无显著差异。然而,在腺癌组中,支气管起源的肿瘤(5/9;56%)中LOH似乎比实质腺癌(6/21;29%)更常见。对所有在一个或多个多态性位点显示LOH的32例肿瘤,通过单链构象多态性(SSCP)分析检测APC基因的突变簇区域(MCR)中的突变。在这些病例中均未检测到突变。因此,我们认为5号染色体上除APC之外的一个肿瘤抑制基因可能参与了肺癌的发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验